Evidence map›Paper›PMID 37693531›Full record

ArticlebioRxiv : the preprint server for biology2023

Spatiotemporal development of the human T follicular helper cell response to Influenza vaccination.

Stefan A Schattgen, Jackson S Turner, Mohamed A Ghonim, Jeremy Chase Crawford, Aaron J Schmitz, Hyunjin Kim, Julian Q Zhou, Walid Awad, Wooseob Kim, Katherine M McIntire and 8 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Stefan A SchattgenDepartment of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
Jackson S TurnerDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Mohamed A GhonimDepartment of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
Jeremy Chase CrawfordDepartment of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
Aaron J SchmitzDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Hyunjin KimDepartment of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
Julian Q ZhouDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Walid AwadDepartment of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
Wooseob KimDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Katherine M McIntireDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Alem HaileClinical Trials Unit, Washington University School of Medicine, St. Louis, MO, USA.
Michael K KlebertClinical Trials Unit, Washington University School of Medicine, St. Louis, MO, USA.
Teresa SuessenMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
William D MiddletonMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Sharlene A TeefeyMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Rachel M PrestiDivision of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Ali H EllebedyDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Paul G ThomasDepartment of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
Washington University in St. Louis · USSt. Jude Children's Research Hospital · USMallinckrodt (United States) · US

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00016 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBBY, RICHARD · 2021 to 2025
$91.4M
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)U01AI144616 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GORDON, AUBREE L, THOMAS, PAUL G. · 2019 to 2025
$43.7M
DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHCR01AI136514 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Paul G. Thomas · 2018 to 2026
$6.9M
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSESU01AI150747 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2020 to 2024
$5.9M
Programming Durable Immune Responses To VaccinationU01AI141990 · NIAID · WASHINGTON UNIVERSITY · PI Ali Hassan Ellebedy · 2019 to 2026
$5.3M
DIVISION OF LABOR IN HUMAN B CELL RESPONSES TO INFLUENZA VIRUSESR21AI139813 · NIAID · WASHINGTON UNIVERSITY · PI ELLEBEDY, ALI HASSAN · 2018 to 2019
$419k
NIAID NIH HHS 75N93019C00052NIAID NIH HHS 75N93021C00016NIAID NIH HHS HHSN272201400006CNIAID NIH HHS R01 AI136514NIAID NIH HHS R21 AI139813NIAID NIH HHS U01 AI141990NIAID NIH HHS U01 AI144616NIAID NIH HHS U01 AI150747
6 · The paper itself

Abstract

We profiled blood and draining lymph node (LN) samples from human volunteers after influenza vaccination over two years to define evolution in the T follicular helper cell (TFH) response. We show LN TFH cells expanded in a clonal-manner during the first two weeks after vaccination and persisted within the LN for up to six months. LN and circulating TFH (cTFH) clonotypes overlapped but had distinct kinetics. LN TFH cell phenotypes were heterogeneous and mutable, first differentiating into pre-TFH during the month after vaccination before maturing into GC and IL-10+ TFH cells. TFH expansion, upregulation of glucose metabolism, and redifferentiation into GC TFH cells occurred with faster kinetics after re-vaccination in the second year. We identified several influenza-specific TFH clonal lineages, including multiple responses targeting internal influenza proteins, and show each TFH state is attainable within a lineage. This study demonstrates that human TFH cells form a durable and dynamic multi-tissue network.

Identifiers

PMID37693531
PMCPMC10491263
OpenAlexW4386328152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.